Canada Markets closed

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.01+0.59 (+9.19%)
At close: 04:00PM EST
6.70 -0.31 (-4.42%)
After hours: 07:27PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close6.42
Open6.32
Bid7.07 x 1200
Ask7.53 x 900
Day's Range6.32 - 7.33
52 Week Range3.55 - 9.59
Volume254,448
Avg. Volume201,945
Market Cap416.553M
Beta (5Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

    CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10th at 4:30 p.m. PST in San Francisco, CA. A live webcast of the company presentation will be available on the investor section of the company website at investors.generationbio.com. About Generation Bio

  • GlobeNewswire

    Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results

    Cash balance of $301.2M expected to fund operations into 2025CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and third quarter 2022 financial results. “Generation Bio’s mission is to unlock the full promise of genetic medicine by developing novel durable, redosable and titratable DNA therapeutics,” said Geoff McDonough, M.D.,

  • GlobeNewswire

    Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit

    CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell & Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com.